Important: This article summarises published clinical research and guidance for general informational purposes only. It does not constitute medical or dermatological advice. Switching or starting a pill for acne management should always be discussed with your GP or dermatologist, who can assess your individual health history, VTE risk factors, and skin type before making a recommendation.

Acne is one of the more common reasons people mention when they talk about starting or switching the combined pill. The relationship between hormones and skin is well-established, and some pills do have documented, clinically recognised effects on acne. Others can make acne worse. The difference comes down to the type of progestogen in the pill, how it interacts with androgen receptors, and how much the pill raises a protein called SHBG.

This article breaks down the mechanism, the evidence, which pills are more likely to help, and what timeline to expect.


Why Hormones Affect Acne

Acne formation involves several factors: sebum (oil) production, follicle blockage, bacterial activity, and inflammation. Androgens, the group of hormones that includes testosterone, directly stimulate sebaceous (oil) glands. Higher levels of circulating androgens, or greater sensitivity to them at the receptor level, typically mean more sebum production and a higher likelihood of blocked pores and breakouts.

In people with a uterus, androgens are produced primarily in the ovaries and adrenal glands. Testosterone circulates partly free (biologically active) and partly bound to a protein called sex hormone-binding globulin (SHBG). Free testosterone is the active form that reaches androgen receptors in the skin.

The combined pill raises SHBG levels significantly, particularly pills containing ethinylestradiol. Higher SHBG means more testosterone gets bound up and less remains free to act on sebaceous glands. This is the foundation of the pill's acne-clearing effect in most combined formulations.

However, the progestogen component of the pill complicates things. Different progestogens have different androgenic activity, ranging from strongly anti-androgenic (actively blocking androgen receptors) to androgenic (capable of stimulating them). This variation is what drives the difference between a pill that improves acne and one that worsens it.


Progestogen Androgenicity: A Spectrum

Progestogens used in contraceptive pills sit across a spectrum of androgenic activity. The table below summarises the key progestogens, their androgenic profile, and the pills that contain them. Always confirm your specific pill's formulation with your pharmacist or prescriber.

Progestogen Androgenic activity Common pills containing it
Cyproterone acetate Strongly anti-androgenic Co-cyprindiol (Dianette, Clairette)
Drospirenone Anti-androgenic Yasmin, Lucette, Eloine
Norgestimate Low androgenic activity Cilest, Estarylla
Gestodene Mildly androgenic or neutral Femodene, Millinette
Desogestrel Mildly androgenic or neutral Gedarel (combined); Cerelle, Cerazette (mini-pill)
Norethisterone Mildly androgenic Loestrin, Micronor (mini-pill)
Levonorgestrel Androgenic Microgynon, Rigevidon, Ovranette

The key distinction for acne is whether the progestogen has anti-androgenic, neutral, or androgenic activity. Androgenic progestogens can partially offset the SHBG-raising effect of the oestrogen component and may directly stimulate sebaceous glands.


Which Pills Help With Acne

Co-cyprindiol (Dianette, Clairette)

Co-cyprindiol is the combined pill with the strongest evidence for acne treatment. It contains ethinylestradiol and cyproterone acetate, the latter being a potent androgen receptor blocker. It works by both raising SHBG (reducing free testosterone) and directly preventing androgens from activating their receptors in the skin.

In the UK, co-cyprindiol is specifically licensed for the treatment of moderate to severe acne and hirsutism in women for whom other treatments have not worked or are not suitable. NICE guidance acknowledges its clinical use in these indications.

Co-cyprindiol is not primarily licensed as a contraceptive in the UK, though it does provide contraceptive protection. It is typically prescribed by a GP or dermatologist for acne specifically, rather than as a routine contraceptive choice.

Co-cyprindiol carries a higher risk of venous thromboembolism (VTE, blood clots) compared to combined pills containing levonorgestrel. MHRA guidance states that co-cyprindiol should generally be stopped three to four months after acne has resolved and should not be used solely as a long-term contraceptive. See our article on the pill and blood clots for more on what VTE risk numbers mean in practice.

Drospirenone pills (Yasmin, Lucette, Eloine)

Drospirenone is a progestogen derived from spironolactone, which has well-documented anti-androgenic properties. Drospirenone-containing pills raise SHBG and also have mild androgen receptor blocking activity.

Van Vloten et al., 2002 — Cutis

This randomised controlled trial comparing drospirenone and cyproterone acetate-containing combined pills found that both formulations produced statistically significant reductions in acne lesion counts and sebum production compared to baseline. The drospirenone-containing pill demonstrated meaningful anti-androgenic effects on skin, supporting its clinical use in acne-prone patients alongside contraception. The authors noted that androgenic activity of the progestogen component was the key differentiating factor between pill formulations for skin outcomes.

In the US, Yaz (drospirenone plus a lower dose of ethinylestradiol) is specifically approved by the FDA for acne treatment. In the UK, drospirenone pills such as Yasmin and Lucette are not specifically licensed for acne but are frequently prescribed for their skin benefits alongside contraceptive use.

These pills carry a moderately higher VTE risk than levonorgestrel-containing pills, though lower than co-cyprindiol. The absolute numbers remain small for most healthy adults without additional risk factors.

Norgestimate pills (Cilest)

Norgestimate is considered to have low androgenic activity and is one of the progestogens cleared by the FDA in the US as part of an approved combination pill for acne treatment. Clinical trials have demonstrated meaningful reductions in inflammatory acne lesion counts. Cilest is the main norgestimate-containing pill available in the UK.


Which Pills May Worsen Acne

Levonorgestrel pills (Microgynon, Rigevidon, Ovranette)

Levonorgestrel is one of the older progestogens and has noticeable androgenic activity. While these pills still raise SHBG due to their oestrogen component, the androgenic activity of levonorgestrel can partially counteract this effect on skin.

For some people, particularly those whose acne has an androgenic component, switching from a higher-androgenic pill such as Microgynon to a lower-androgenic or anti-androgenic pill produces visible improvement. Conversely, switching from an anti-androgenic pill to Microgynon can be associated with a return or worsening of acne.

This is not a universal experience. Many people take Microgynon without any skin effects. But if you are on a levonorgestrel pill and struggling with acne, the androgenicity of the progestogen is worth discussing with your GP.

The mini-pill

The progestin-only pill does not contain oestrogen, which means it does not raise SHBG in the same way as combined pills. Without the SHBG-raising effect, there is less reduction in free androgens. Some people find the mini-pill is associated with acne or does not improve pre-existing acne.

Desogestrel-containing mini-pills (Cerelle, Cerazette) suppress ovulation in most cycles, which does reduce ovarian androgen production to some extent. The picture with the mini-pill and acne is therefore more variable than with combined pills. If acne management is a priority in your contraceptive choice, a combined pill is generally the more predictable option, subject to your eligibility for oestrogen-containing methods.


How Long Does the Pill Take to Clear Acne?

Research consistently shows that hormonal effects on skin take time. Most clinical trials assessing the pill's effect on acne measure outcomes over six months, not six weeks. The general pattern observed across the literature:

  • Weeks 1 to 4: Hormonal adjustment phase. Some people experience a temporary worsening of acne during the first one to three cycles as the body adjusts to a new hormonal environment.
  • Months 2 to 3: Early improvement may be visible for some, particularly reduction in inflammatory lesions.
  • Months 4 to 6: More significant clearing is typically evident by this point for those who will respond positively.
  • Beyond 6 months: Further gradual improvement often continues for some individuals.

Expecting dramatic change within the first month is likely to lead to premature switching. Dermatologists and GPs generally advise allowing a minimum of three to six months on a pill before assessing its effect on acne.

A temporary worsening in the first one to three cycles is not a sign that the pill is wrong for you. The hormonal adjustment period is well-documented. Unless the worsening is severe or accompanied by other concerning symptoms, most clinical guidance recommends continuing for at least three months before reassessing.


SHBG and Acne: The Mechanism in More Detail

Sex hormone-binding globulin is a protein produced by the liver. It binds to sex hormones, including testosterone, and when bound, those hormones cannot reach tissue receptors. The ethinylestradiol in combined pills strongly stimulates liver SHBG production. Research has shown that combined pills can increase SHBG levels by four-fold or more compared to baseline in some individuals.

Arowojolu et al., 2012 — Cochrane Database of Systematic Reviews

This Cochrane systematic review evaluated the evidence for combined oral contraceptive pills in the treatment of acne. The review found that combined pills containing cyproterone acetate or drospirenone were consistently associated with greater reductions in acne lesion counts than pills with more androgenic progestogens. The authors noted that all combined pills raised SHBG, but the net effect on skin depended substantially on the androgenic profile of the progestogen component. They concluded that combined pills are effective treatments for acne in women who also require contraception, with formulation choice being clinically meaningful.

Pills with anti-androgenic progestogens maximise the reduction in free androgens available to reach skin receptors. Pills with androgenic progestogens blunt the SHBG-raising effect and may partially stimulate androgen receptors directly. This is why two women on different combined pills can have opposite experiences with acne on the same class of medication.


Acne, the Pill, and What to Discuss With Your GP

A few things worth raising with your GP or dermatologist if you want to explore the pill as part of your acne management:

The type of acne matters. Hormonal acne, typically characterised by deep cystic lesions around the jawline and chin that worsen around the time of a period, is more likely to respond to hormonal intervention than acne driven primarily by blocked pores or bacterial activity.

Your current pill may be contributing. If you are already taking a pill with an androgenic progestogen and experiencing acne, switching formulation is a straightforward conversation to have with your GP.

Co-cyprindiol has the strongest acne-specific evidence but is prescribed for that indication specifically, not for long-term contraceptive use alone. Your GP may recommend it for a defined period and then reassess.

A dermatology referral is appropriate if acne is severe, persistent, or significantly affecting quality of life. Systemic treatments such as isotretinoin or additional topical treatments may be considered alongside or instead of a hormonal approach, and a dermatologist is best placed to advise on the full range of options.

Track with Estroclic

Keep an accurate log of every pill you take

If you are monitoring your skin while on a new pill, having a precise record of when you took each dose and any days you missed helps you and your GP interpret how your skin is responding. Estroclic tracks your pill-taking history accurately so you can bring real data to your next appointment.

Download on Android

Frequently asked questions

Does the birth control pill help with acne?

Some combined pills are clinically documented to improve acne. Pills containing anti-androgenic progestogens, particularly drospirenone or cyproterone acetate, reduce free androgen activity and sebum production. Pills with androgenic progestogens such as levonorgestrel may have minimal benefit and can worsen acne in some people. The mini-pill, which lacks oestrogen, does not raise SHBG in the same way and is generally less effective for acne. Always consult your GP or dermatologist before switching pill for skin reasons.

Which pill is best for acne?

Co-cyprindiol (Dianette, Clairette) has the strongest clinical evidence for acne treatment and is specifically licensed for this purpose in the UK. Drospirenone-containing pills such as Yasmin and Lucette are also documented to reduce acne lesion counts across multiple randomised trials. Your GP can advise which is appropriate given your individual health profile, including VTE risk factors, as co-cyprindiol carries a higher clot risk than most combined pills.

Can the pill make acne worse?

Yes. Pills containing androgenic progestogens such as levonorgestrel can worsen acne, or fail to improve pre-existing acne, particularly in people whose acne has a hormonal component. The mini-pill may also be associated with acne in some people due to its lack of oestrogen and therefore reduced SHBG-raising effect. A temporary worsening during the first one to three cycles is also common when starting any new pill, as the body adjusts to a new hormonal environment.

How long does it take for the pill to clear acne?

Most clinical research measures pill effects on acne over three to six months. Visible improvement typically begins around months two to three, with more significant clearing evident by months four to six for those who will respond positively. A temporary worsening during the first one to three cycles is not unusual as hormones adjust. Dermatologists and GPs generally advise allowing a minimum of three to six months before assessing a pill's effect on skin.

Does Yasmin clear acne?

Yasmin contains drospirenone, an anti-androgenic progestogen derived from spironolactone. Clinical trials demonstrate statistically significant reductions in acne lesion counts with drospirenone-containing pills compared to placebo. Yasmin and its generic equivalents such as Lucette are frequently used for acne benefits alongside contraception in the UK, though they are not specifically licensed for acne here as the equivalent formulation Yaz is in the US. Speak to your GP to assess whether it is appropriate for you.

Does Microgynon cause acne?

Microgynon contains levonorgestrel, which has androgenic activity. Some people find that Microgynon is associated with acne or does not improve pre-existing acne, particularly where acne has an androgen-driven component. This is not a universal experience and many people take Microgynon without any skin effects. If you are on a levonorgestrel pill and concerned about acne, switching to a lower-androgenic or anti-androgenic formulation is worth discussing with your GP.

Is co-cyprindiol safe for long-term use?

Co-cyprindiol carries a higher risk of venous thromboembolism than most combined pills and is not recommended for long-term use as a sole contraceptive method. MHRA guidance recommends stopping co-cyprindiol three to four months after the skin condition for which it was prescribed has resolved. Any continued use should be under GP review with regular reassessment of risks and benefits.

This article is for general informational purposes only and does not constitute medical, dermatological, or clinical advice. The information presented summarises published research and clinical guidance at the time of writing and may not reflect the most current guidance in your country or for your individual circumstances. Pill formulations, licensing status, and prescribing guidance vary between countries. Always consult your GP, dermatologist, or pharmacist before starting, stopping, or switching any hormonal contraceptive, including for the purpose of acne management. Estroclic is a personal tracking app, not a medical device or clinical service.
Sources
  • Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;11:CD004425. Systematic review evaluating the evidence base for combined pills in acne treatment. Found that pills with anti-androgenic progestogens, particularly cyproterone acetate and drospirenone, produced the most consistent reductions in acne lesion counts. Concluded that progestogen androgenicity is the key differentiating factor between formulations. pubmed.ncbi.nlm.nih.gov
  • van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R. The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis. 2002;69(4 Suppl):2-15. Randomised controlled trial demonstrating statistically significant reductions in acne lesion counts and sebum production with both drospirenone and cyproterone acetate-containing combined pills, supporting the anti-androgenic mechanism as a clinically meaningful effect on skin. pubmed.ncbi.nlm.nih.gov
  • MHRA Drug Safety Update. Co-cyprindiol: updated guidance on risks of venous thromboembolism and arterial thromboembolism. Medicines and Healthcare products Regulatory Agency, UK. Guidance confirming that co-cyprindiol carries a higher VTE risk than most combined pills containing levonorgestrel, and should be stopped three to four months after the condition for which it was prescribed has resolved. gov.uk
  • Thiboutot D, Archer DF, Lemay A, Washenik K, Roberts J, Harrison DD. A randomized, controlled trial of a low-dose contraceptive containing 20 mcg of ethinyl estradiol and 100 mcg of levonorgestrel for acne treatment. Fertil Steril. 2001;76(3):461-468. Trial demonstrating that even pills with androgenic progestogens show some acne benefit from oestrogen-driven SHBG elevation, but with substantially smaller effect sizes than pills with anti-androgenic progestogens, illustrating the importance of progestogen selection. pubmed.ncbi.nlm.nih.gov